Wusheng Erlunbao: Sinopharm’s First‑of‑Its‑Kind Hexavalent Rotavirus Vaccine Receives NMPA Approval
The Wuhan Institute of Biological Products Co., Ltd., a subsidiary of Sinopharm Group Co., Ltd....
Vaccine
Kangtai Biological Gains NMPA Approval for Trivalent Influenza Vaccine Clinical Trial
Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601) announced that it has received approval from...
Zhifei Biological’s Adult and Adolescent DTaP Vaccine Gains NMPA Trial Approval
Chongqing Zhifei Biological Co., Ltd. (SHE: 300122), based in China, announced that its Acellular Pertussis,...
Ab&B Bio-Tech’s RSV Vaccine Gains IND Approval in China and the U.S.
China-based Ab&B Bio-Tech CO., LTD. JS (HKG: 2627) announced that its self-developed investigational new drug...
Hualan Biological Gains NMPA Approval for Hib Vaccine Clinical Trials
Hualan Biological Engineering Inc., (SHE: 002007) announced that its freeze-dried Haemophilus influenzae type b (Hib)...
Westgene Partners with BGI Huo-Yan for mRNA Drug Development and Industrialization
Chengdu Westgene Biopharma announced the establishment of a strategic partnership with Shenzhen BGI Huo-Yan Engineering...
Sanofi to Acquire Vicebio Ltd for Up to USD 1.6 Billion, Advancing Next-Gen Vaccine Development
Vicebio Ltd has entered into an exclusive, definitive agreement to be acquired by France-based major...
CanSino Bio Receives NMPA Approval for Phase I/II Trial of Recombinant Polio Vaccine
China-based CanSino Biologics Inc., (HKG: 6185) announced that it and its subsidiary CanSino (Shanghai) Biotechnology...
GSK’s Arexvy RSV Vaccine Expansion for Adults 18-49 Receives FDA Review
UK-based GlaxoSmithKline (GSK; NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has...
Recbio Partners with Biological E for HPV VaccineREC603’s India and Global Expansion
China-based Jiangsu Recbio Technology Co., Ltd. (HKG: 2179) announced a licensing agreement with India-headquartered Biological...
CanSino Biologics’ PCV13i Vaccine Gains NMPA Approval
China-based CanSino Biologics Inc., (HKG: 6185) announced that the National Medical Products Administration (NMPA) has...
Wantai Biological Launches Phase III Trial for VZV-7D Varicella Vaccine
China-based Beijing Wantai Biological Pharmacy Enterprise Co., Ltd (SHA: 603392) has announced the initiation of...
Changchun BCHT Gains NMPA Approval for BK-01 Adjuvanted Influenza Vaccine
China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) announced that it has received clinical trial...
Sanofi and Abu Dhabi Department of Health Collaborate to Accelerate Vaccine Development
France major Sanofi (NASDAQ: SNY) this week signed a Memorandum of Understanding (MoU) with the...
Clover Biopharmaceuticals Completes Enrollment for Phase I Trial of RSV + hMPV Combination Vaccines
China-based Clover Biopharmaceuticals Ltd., (HKG: 2197) announced the completion of enrollment for the first participants...
Clover Biopharmaceuticals Terminates Adimmune Influenza Vaccine Pact Over Market Shifts
China-based Clover Biopharmaceuticals Ltd., (HKG: 2197) announced the exercise of unilateral termination rights under its...
GSK Seeks EMA Approval to Expand RSV Vaccine Arexvy Use to Adults Aged 18+
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) has announced that the European Medicines Agency (EMA)...
GSK Licenses Shigella Vaccine to Bharat Biotech for Low- and Middle-Income Countries
UK-based GSK plc (NYSE: GSK) announced a licensing agreement with Bharat Biotech International Limited, an...
Merck Launches Phase III Trial for Quadrivalent Dengue Vaccine V181
US-based Merck, Sharp & Dohme (MSD; NYSE: MRK) announced the launch of the Phase III...
NeoCura Bio-Medical Gains NMPA Approval for mRNA Cancer Vaccine Trial
China-based NeoCura Bio-Medical Technology Co., Ltd. announced that it has received approval from the National...